465 studies on Tirzepatide curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This case report carries significant clinical implications, particularly for endocrinologists and primary care providers prescribing tirzepatide to patients with complex endocrine histories. The finding underscores th…
This systematic review provides compelling evidence that THR-β agonists may represent a more effective treatment strategy for noncirrhotic MASH compared to incretin therapies, particularly concerning histological reso…
The successful completion of SURMOUNT-CN is a crucial step towards expanding the availability of effective obesity treatments globally, specifically addressing the needs of the Chinese population. Tirzepatide, a dual …
Understanding the direct haemodynamic mechanisms of semaglutide and tirzepatide is crucial for optimizing their use in patients with cardiovascular diseases. This research could reveal novel pathways through which the…
This summary from an ICER council is crucial because it provides an independent, evidence-based assessment of the clinical and economic value of two highly effective anti-obesity medications. Such reviews are instrume…
Understanding the specific metabolic shifts induced by Semaglutide and Tirzepatide is crucial for optimizing obesity treatment strategies. If the study reveals significant, sustained improvements in energy expenditure…
This Phase 2 trial is crucial as it explores a novel combination therapy that could significantly advance the treatment landscape for obesity and Type 2 Diabetes. If successful, combining LY3841136 with Tirzepatide co…
This study addresses a critical unmet need for patients with psoriatic arthritis who also struggle with obesity, a common comorbidity that complicates disease management and often reduces the effectiveness of existing…
This research underscores a critical challenge in obesity management, suggesting that the benefits of Tirzepatide on weight loss may necessitate continuous or long-term administration to prevent relapse. The rapid wei…
Understanding the effects of GLP-1 agonist discontinuation is crucial for informing patient care and developing strategies to manage potential rebound effects and improve long-term outcomes. Many patients may need to …
Tirzepatide is already a highly effective treatment for Type II Diabetes and obesity, known for its significant glycemic control and weight loss benefits. The key implication of this study is that if Tirzepatide can d…
This study provides compelling real-world evidence that low-to-moderate doses of Tirzepatide are highly effective and well-tolerated for weight management in adults with obesity in routine clinical practice. The obser…
This review underscores the critical role of tailored dietary strategies in maximizing the therapeutic benefits of GLP-1 and dual GIP/GLP-1 receptor agonists. It suggests that integrating specific nutritional guidance…
This study provides crucial real-world evidence that Tirzepatide not only induces substantial weight loss but also favorably alters body composition by preserving lean mass and significantly improving muscle function …
This comprehensive review underscores that optimizing nutritional support is absolutely essential for maximizing the therapeutic benefits and minimizing potential risks associated with GLP-1 receptor agonist therapies…
This comprehensive systematic review solidifies the evidence for GLP-1 RAs as crucial therapeutic agents for cardiovascular protection, extending their benefits far beyond glucose control and weight management. These …
This comprehensive review provides crucial evidence for clinicians to make informed decisions when prescribing pharmacological interventions for weight management in non-diabetic adults. The significant weight loss ob…
This review is crucial for guiding future research and clinical practice in the rapidly evolving landscape of GLP-1 therapies, emphasizing a holistic approach to patient care. Understanding the psychological dimension…
This comprehensive real-world data provides crucial insights for clinicians and patients navigating treatment options for Type 2 Diabetes and obesity. The findings underscore Tirzepatide's potential for greater metabo…
Tirzepatide has already demonstrated significant efficacy, and exploring higher or alternative dosing strategies could further optimize patient outcomes by potentially enhancing glycemic control and weight loss. This …
The successful completion of this Phase 3 trial is a significant milestone, as Tirzepatide (a dual GIP and GLP-1 receptor agonist) has already demonstrated robust efficacy in adults with Type 2 Diabetes and obesity. I…
This Phase 3b study represents a significant step towards developing more holistic treatment strategies for complex conditions. If successful, combining Mirikizumab and Tirzepatide could offer a novel therapeutic opti…
Tirzepatide offers a powerful new treatment option for Type 2 Diabetes Mellitus, particularly for those struggling to achieve adequate glycemic control with existing therapies. The successful completion of this Phase …
This real-world study provides compelling evidence that treatment persistence is a critical determinant for maximizing the comprehensive benefits of Tirzepatide across the spectrum of Cardio-Metabolic-Kidney Syndrome.…
The successful completion of this Phase 1/2 trial for IBI362 could significantly impact the landscape of obesity treatment, particularly for the Chinese patient population. If IBI362 demonstrates a favorable safety pr…
The development of multi-agonist incretin therapies and novel non-incretin pathways represents a critical advancement, offering more potent and comprehensive treatment options for obesity and Type 2 Diabetes than ever…
This review underscores the critical and enduring role of bariatric surgery as the most efficacious treatment for obesity, even amidst the revolutionary advancements in GLP-1 RA pharmacotherapy. Recognizing the unique…
This study provides compelling evidence that GLP-1 Receptor Agonists offer significant protective benefits beyond glycemic control, extending to both systemic and ocular vascular health in a high-risk population. Thes…
The successful outcome of this trial could represent a paradigm shift in managing the complex interplay of Type 1 Diabetes and obesity. If Tirzepatide proves safe and effective, it could offer a novel therapeutic opti…
This study is crucial for understanding Tirzepatide's performance in patient groups often excluded from or underrepresented in randomized controlled trials. If successful, it could provide valuable evidence supporting…
If successful, this study could identify a simple, accessible, and enjoyable dietary intervention to optimize the benefits of GLP-1 therapy, potentially mitigating unwanted muscle loss and enhancing overall health out…
This study provides crucial evidence for policymakers, demonstrating the significant economic and health benefits of investing in comprehensive obesity management programs. By integrating more nuanced data on T2D prog…
This review is crucial because it highlights the escalating global obesity crisis and the urgent need for novel, potentially safer, and more accessible therapeutic options. By systematically exploring natural products…
This case report highlights a rare but significant potential adverse effect of semaglutide, suggesting it may induce hypercapnia in susceptible individuals even with normal lung function. This finding underscores the …
Preserving lean body mass during weight loss is crucial for maintaining metabolic health, physical strength, and preventing conditions like sarcopenia (age-related muscle loss). If successful, this study could provide…
This study represents a pivotal advancement in the treatment landscape for obstructive sleep apnea, offering a highly effective pharmacological approach that directly addresses a major underlying cause: obesity. The s…
Preserving lean muscle mass is critical for maintaining metabolic health, strength, and overall quality of life during significant weight loss. If successful, this intervention could become a standard recommendation f…
This study highlights a critical safety consideration for patients undergoing free flap breast reconstruction who are also using GLP-1 RAs. The observed increase in serious wound complications, particularly flap necro…
This study provides crucial evidence supporting the economic value of Tirzepatide for a complex patient population suffering from HFpEF and obesity. These findings could significantly influence clinical guidelines, fo…
This study provides a robust, integrated safety profile for widely used GLP-1 RAs, offering a more complete picture than individual studies alone. Understanding these comprehensive safety data is crucial for informing…
This study provides crucial economic evidence for healthcare payers and policymakers in the US, suggesting that the superior efficacy of tirzepatide translates into significant long-term health benefits and a favorabl…
This comprehensive meta-analysis provides compelling real-world evidence that GLP-1-based therapies offer substantial benefits beyond glycemic control and cardiovascular protection, extending to critical limb outcomes…
This study provides compelling real-world evidence that tirzepatide offers superior benefits in preventing the progression of cardiovascular-kidney-metabolic syndrome compared to other GLP-1 receptor agonists. The sig…
This study provides critical insights into the pharmacovigilance of drug-associated ketoacidosis, highlighting specific drug classes that warrant increased clinical vigilance. The strong signal for SGLT2 inhibitors re…